Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial (Q46578469)
scientific article published on January 15, 2012
Language:
(P31) (Q13442814)
(P304) 61-68
(P407) (Q1860)
(P433) 1
(P478) 93
(P577) Sunday, January 1, 2012
Sunday, January 15, 2012
(P921) (Q6946)
(Q423384)
(P953) https://journals.lww.com/transplantjournal/Fulltext/2012/01150/Valganciclovir_Prophylaxis_Versus_Preemptive.10.aspx
https://journals.lww.com/10.1097/TP.0b013e318238dab3
(P1433) (Q15730500)
(P1476) "Valganciclovir prophylaxis versus preemptive therapy in cytomegalovirus-positive renal allograft recipients: 1-year results of a randomized clinical trial" (language: en)
"Valganciclovir Prophylaxis Versus Preemptive Therapy in Cytomegalovirus-Positive Renal Allograft Recipients: 1-Year Results of a Randomized Clinical Trial" (language: en)
(P2093) Oliver Witzke
Michael Bartels
Gunter Wolf
Heiner Wolters
Martin Nitschke
VIPP Study Group
Ingeborg A. Hauser
(P2860) (Q44188441)
(Q44939151)
(Q36167258)
(Q45037412)
(Q73939234)
(Q52947848)
(Q44407642)
(Q44899005)
(Q36006091)
(Q95824603)
(Q37283970)
(Q37778827)
(Q46764122)
(Q79775594)
(Q36787493)
(Q57712171)
(Q47850193)
(Q30439686)
(Q33962859)
(Q39664628)
(Q47869308)
(Q25938997)
(Q47588320)
other details
description scientific article published on January 15, 2012

External Links